Cargando...
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
Programmed death 1 (PD-1, CD279) and programmed death ligand 1 (PD-L1, CD274) are involved in generating tumor-associated immunosuppression by suppression of T-cell proliferation and interleukin 2 (IL-2) production and immune checkpoint inhibitors targeting these molecules are showing compelling act...
Gardado en:
| Publicado en: | Clin Neuropathol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dustri-Verlag Dr. Karl Feistle
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4766797/ https://ncbi.nlm.nih.gov/pubmed/26501438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300922 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|